HealthcareAug 10, 2026

Sangamo Therapeutics

Company Profile Analysis

Book Demo Subscribe Now

Sangamo Therapeutics - Healthcare showcase

Year Founded & Workforce

1994-12-31

500 Employees

Industry

Healthcare

Services

Sangamo Therapeutics Overview

Company Headquarters: California, US

Founded: 1995

Workforce: ~500

Company Working: Sangamo Therapeutics is a clinical-stage biopharmaceutical company which is engaged in the development of new medicines for the treatment of serious genetic diseases. It develops genomic medicines to change the lives of patients with serious diseases. The company is developing a strong, sustainable, differentiated, innovative, and genomic medicine pipeline that helps patients with life-limiting conditions. The company uses proprietary zinc finger genome engineering technology and manufacturing expertise for the development of new medicines. It has a strong business presence in the North America region.

Strategy

Sangamo Therapeutics focuses on developing a diversified product portfolio by the innovation and development of products, thus delivering integrated solutions to large healthcare customers. It also emphasizes collaborations to enhance its market presence in the industry. Its strategy is to use science-based innovation to deliver better patient outcomes. It is also committed to the principle of equal employment opportunity out of moral and legal obligations.

Company Snapshot

$102.4M

Revenue

500

Employees

1994-12-31

Founded

California, US

Headquarters

SWOT Analysis

Strengths

Strong customer base
Provides high-quality and cost-effective products
Skilled workforce

Weaknesses

Limited financial capital
Limited product portfolio in gene editing market

Opportunities

Adoption of new technology for development of gene editing
Rising demand for gene editing

Threats

Strong competition from international key players
Fluctuation in foreign currency

Key Developments

Date	Approach	Development
February 2020	Collaboration	Sangamo Therapeutics, Inc announced collaboration agreement with Biogen (US) for the development of gene regulation therapies for Alzheimer’s, Parkinson’s, neuromuscular, and other neurological diseases. By this collaboration company expand their product portfolio.

Product Offering

Sangamo Therapeutics
- Gene Editing

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Sangamo Therapeutics as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Sangamo Therapeutics

Company Headquarters: California, US Founded: 1995 Workforce: ~500 Company Working: Sangamo Therapeutics is a clinical-stage biopharmaceutical company which is engaged in the development of new medicines for the treatment of serious genetic diseases. It develops genomic medicines to change the lives of patients with serious diseases. The company is developing a strong, sustainable, differentiated, innovative, and genomic medicine pipeline that helps patients with life-limiting conditions. The company uses proprietary zinc finger genome engineering technology and manufacturing expertise for the development of new medicines. It has a strong business presence in the North America region.

Starting from

$4,950